Steinhof-Radwańska, K.; Grażyńska, A.; Lorek, A.; Gisterek, I.; Barczyk-Gutowska, A.; Bobola, A.; Okas, K.; Lelek, Z.; Morawska, I.; Potoczny, J.;
et al. Contrast-Enhanced Spectral Mammography Assessment of Patients Treated with Neoadjuvant Chemotherapy for Breast Cancer. Curr. Oncol. 2021, 28, 3448-3462.
https://doi.org/10.3390/curroncol28050298
AMA Style
Steinhof-Radwańska K, Grażyńska A, Lorek A, Gisterek I, Barczyk-Gutowska A, Bobola A, Okas K, Lelek Z, Morawska I, Potoczny J,
et al. Contrast-Enhanced Spectral Mammography Assessment of Patients Treated with Neoadjuvant Chemotherapy for Breast Cancer. Current Oncology. 2021; 28(5):3448-3462.
https://doi.org/10.3390/curroncol28050298
Chicago/Turabian Style
Steinhof-Radwańska, Katarzyna, Anna Grażyńska, Andrzej Lorek, Iwona Gisterek, Anna Barczyk-Gutowska, Agnieszka Bobola, Karolina Okas, Zuzanna Lelek, Irmina Morawska, Jakub Potoczny,
and et al. 2021. "Contrast-Enhanced Spectral Mammography Assessment of Patients Treated with Neoadjuvant Chemotherapy for Breast Cancer" Current Oncology 28, no. 5: 3448-3462.
https://doi.org/10.3390/curroncol28050298
APA Style
Steinhof-Radwańska, K., Grażyńska, A., Lorek, A., Gisterek, I., Barczyk-Gutowska, A., Bobola, A., Okas, K., Lelek, Z., Morawska, I., Potoczny, J., Niemiec, P., & Szyluk, K.
(2021). Contrast-Enhanced Spectral Mammography Assessment of Patients Treated with Neoadjuvant Chemotherapy for Breast Cancer. Current Oncology, 28(5), 3448-3462.
https://doi.org/10.3390/curroncol28050298